Literature DB >> 31517668

Impact of Menopausal Status on Uropathogen Prevalence and Antimicrobial Resistance Profiles.

Kristen Venuti1, Camila Cabrera1, Linda S Burkett2, Megan S Bradley2.   

Abstract

OBJECTIVES: The unique factors associated with urinary tract infections (UTIs) in postmenopausal (PMP) women have been significantly less investigated as compared with premenopausal (PreMP) women. Our objective was to compare the prevalence of uropathogens and antibiotic resistance patterns between PreMP and PMP women with UTIs.
METHODS: This was a cross-sectional analysis of PreMP and PMP women treated for a UTI in a urogynecologic practice between November 2016 and November 2017. Diagnostic criteria for UTI included lower urinary tract symptoms and a positive urine culture. Our primary outcome was proportion of non-Escherichia coli UTIs between groups.
RESULTS: We had 370 women with mean (SD) age of 66.7 (12.8) years and body mass index of 29.1 (7.1) kg/m2. Most women were PMP (88.6%). Postmenopausal status did not increase the proportion of non-E. coli UTI (42.7% PMP vs 33.3% PreMP, P = 0.25) or decrease the proportion of pansensitive UTI (36.0% PMP vs 42.9% PreMP, P = 0.38).In multivariable analysis, women with a history of rUTI were at higher odds of having a non-E. coli UTI (adjusted odds ratio, 1.93; 95% confidence interval, 1.21-3.08; P = 0.01) and at lower odds of pansensitive urine culture (adjusted odds ratio, 0.37; 95% confidence interval, 0.22-0.63; P < 0.01) as compared with those without rUTI, when controlling for confounders. Postmenopausal women with a history of rUTI had the highest proportion of non-E. coli UTIs (51.1%, P < 0.01) and lowest proportion of pansensitive uropathogens (29.1%, P < 0.01) as compared with other PMP women and PreMP without a history of rUTI.
CONCLUSIONS: In a urogynecologic population, a history of rUTI, more than menopausal status, significantly impacted the prevalence of specific uropathogens and resistant organisms.
Copyright © 2019 American Urogynecologic Society. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 31517668     DOI: 10.1097/SPV.0000000000000778

Source DB:  PubMed          Journal:  Female Pelvic Med Reconstr Surg        ISSN: 2151-8378            Impact factor:   2.091


  2 in total

1.  Sporadic compared to recurrent urinary tract infections: Considerations for urogynecologic patients.

Authors:  Megan S Bradley; Camila Cabrera; Stephanie Glass Clark; Jessica Sassani; Kristen Venuti; Mary F Ackenbom
Journal:  Neurourol Urodyn       Date:  2020-08-17       Impact factor: 2.696

2.  Home urinary tract infection testing: patient experience and satisfaction with polymerase chain reaction kit.

Authors:  Alexandra I Melnyk; Coralee Toal; Stephanie Glass Clark; Megan Bradley
Journal:  Int Urogynecol J       Date:  2022-08-09       Impact factor: 1.932

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.